Statement of Compliance
Sterling Institutional Review Board (IRB) is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process.
Sterling IRB is organized and operates in compliance with the U.S. Department of Health and Human Services and U.S. Food and Drug Administration regulations for the protection of human subjects as described in 45 CFR Part 46 and 21 CFR Parts 50 and 56 and adheres to the International Conference on Harmonisation (ICH) Good Clinical Practice (GCP) guidelines. Sterling IRB is registered with OHRP/FDA; our IRB registration number is IRB00001790, parent organization number is IORG0001354.
Since 2010, Sterling IRB has been fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Sterling Institutional Review Board’s primary responsibility is to protect the privacy, safety and welfare of the human subject participating in research.
FEATURED NEWS:See All News
Innovation. Passion. Commitment. We believe these are the essential components of strong teamwork.
A diverse group of scientific and non-scientific members with nearly a century of collective IRB experience.
Sterling IRB has formed a strategic partnership with Veritas IRB.